Navigation Links
Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks
Date:2/26/2008

Data published in February issue of Clinical and Vaccine Immunology

ANN ARBOR, Mich., Feb. 26 /PRNewswire/ -- Scientists at NanoBio Corporation and the University of Michigan have demonstrated their nasally delivered vaccinia vaccine can protect animals against 77 times the potentially lethal dose of smallpox, and without the safety risks of current vaccines for smallpox. Vaccinia virus is related to smallpox virus and builds immunity against it.

The new vaccine confers a high level of safety because it contains inactivated vaccinia virus, not the live virus contained in current smallpox vaccines, according to the scientists. Live viruses can elicit adverse reactions; yet previous attempts to use inactivated virus have failed to rouse an adequate immune response against smallpox, the scientists said.

The current study in mice demonstrates that NanoBio's killed-virus vaccine elicits a robust immune response because it delivers immune-alerting antigens directly to the lining of the nasal mucosa, where the virus first enters the body. Immune cells inside the nose immediately recognize the foreign invader and quickly build an immune response against it, a process known as "mucosal" immunity.

Mucosal immunity provides a critical first response against respiratory viruses, yet injected vaccines do not induce mucosal immunity, said James R. Baker Jr., M.D. founder and chairman of NanoBio Corporation. NanoBio is a spin-off from the University of Michigan.

"The key finding is that we have validated in animals a new means of immunization that produces a unique and highly effective immune response without the potential risks of smallpox vaccination that are no longer considered acceptable in the population at large," said Baker.

"The safety and speed of our nasally delivered vaccine would provide the necessary protection to the public in the event of a bioterrorist attack or a natural outbreak of a related orthopoxvirus infectio
'/>"/>

SOURCE NanoBio Corporation
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related biology technology :

1. GelVac(TM) Nasal Powder H5N1 (Bird Flu) Influenza Vaccine Passes Preclinical Toxicology Studies
2. DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program
3. Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
4. GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral)
5. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
6. Vaccinex Antibody Licensed to GlaxoSmithKline
7. Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration
8. NIH Funds Vaccine Research for Needle-free and Self-Administered Protection Against Pandemic Influenza
9. The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions
10. Boost for Malaria Vaccine Development by Combining Strengths of Dutch and American Researchers
11. Transgenes Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , , AMSTERD..., the world,s,leading publisher of scientific, med...nounced a major re-launch of Embase, its comprehen...on indexed records from more than 7,000,active, pe...layed a key role in the advancement of new biomedi...
(Date:11/27/2009)... , , DURHAM, N.C., Nov. 27 /PRNewsw...Park, will initiate water-soluble carbon nanotube-...dia. The water-soluble carbon nanotubes, which hav...onjugation with cancer drugs, was developed in par.... The conjugated carbon nanotubes serves as a drug...
(Date:11/26/2009)... , , WEST LAFAYETTE, Ind. - A new generation of... chips using tiny structures called semiconducting...very by researchers at IBM, Purdue University and ...he researchers have learned how to create nanowire...ply defined at the atomic level, which is a critic...
(Date:11/25/2009)... , Ambassador to Speak at... Toronto, Canada (Vocus) November 25, 2009 -- Amb... , ,Who: ,David Appia, French Ambassador for Inter...nvest in France Agency ,To view a biography of Dav...t: ,Ambassador Appia is available to meet with pre...
Breaking Biology Technology:Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3French Ambassador for International Investment to Visit Toronto December 11 2
... Amarin Corporation plc,(NASDAQ: AMRN ) today an...th,Scarista Limited ("Scarista") for the developme...ctual property portfolio in the field of lipid,sci...lementary to Amarin,s,existing lipid-based develop...pid transport technology. The transaction consider...
...l lead offers flexibility for placement in small, ...s, NATICK, Mass., March 3 Boston Scientific,Corp...oval of its ACUITY(R),Spiral left ventricular lead...fibrillators and cardiac resynchronization therapy...e product features a spiral design and small,lead ...
...gland and PHILADELPHIA, Pennysylvania, March 3, Sh...ecialty biopharmaceutical company, notes that Reno...ounced the results of Renovo,s latest Phase 2,stud...scar revision surgery,(RN1001-319-1009) and in bre...ss release can be found on http://www.renovo.com ...
Other Biology Technology:Amarin Secures Global Intellectual Property Rights for Lipid Programs 2Amarin Secures Global Intellectual Property Rights for Lipid Programs 3Amarin Secures Global Intellectual Property Rights for Lipid Programs 4Boston Scientific Announces European Approval of New Heart Failure Lead 2Boston Scientific Announces European Approval of New Heart Failure Lead 3Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3) 2Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3) 3
(Date:11/26/2009)...hat are the bare essentials of life, the indispens...an survive on its own? Can we describe the molecul... organism functions as a system? These are just so...ip between the European Molecular Biology Laborato...e Regulacio Genmica (CRG) in Barcelona, Spain, set...
(Date:11/25/2009)...sy lives. In addition to mammalian immune systems ...alled bacteriophages, viruses that kill half the b...ria and another class of microorganisms called arc...h as deep-sea volcanic vents) manage just fine, th...nse system that helps protect them from many virus...
(Date:11/25/2009)...heart pumps some 250 million liters of blood throu...ibers of the heart have to be extremely durable. T..., vice chair of the Department of Medicine III at .... H. A. Katus), has discovered a protein that is r...lar unit, the sarcomere. In cooperation with other...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3New genetic cause of cardiac failure discovered 2Specialty Technical Consultants becomes Women Owned Business Enterprise 28WBE 29 13114 1Specialty Technical Consultants becomes Women Owned Business Enterprise 28WBE 29 13114 2Specialty Technical Consultants becomes Women Owned Business Enterprise 28WBE 29 13114 3OB10 and Memorial Hermann Show How e Invoicing Program Optimized Accounts Payables and P Card Spend 52187 1OB10 and Memorial Hermann Show How e Invoicing Program Optimized Accounts Payables and P Card Spend 52187 2OB10 and Memorial Hermann Show How e Invoicing Program Optimized Accounts Payables and P Card Spend 52187 3OB10 and Memorial Hermann Show How e Invoicing Program Optimized Accounts Payables and P Card Spend 52187 4WIN Global Poll Finds Concern Of Swine Flu Decreasing Despite Not Being Prepared For A Pandemic 52183 1WIN Global Poll Finds Concern Of Swine Flu Decreasing Despite Not Being Prepared For A Pandemic 52183 2
...has to be the niche. As air and water preceded lif...shelters adult stem cells in many tissues and prov...l, must have emerged before its stem cell dependen... for Biological Studies led by Leanne Jones, Ph.D....s, now suggests that this is not always the case. ...
...ts from across the U.S. and other countries includ...versity Medical Center will discuss the latest fin... at the 11th International Fragile X Conference, t...children who are diagnosed with Fragile X also wil...romosome-linked condition, is the most common inhe...
...ch help both scientists and regulators to manage u...rch funded by the Economic and Social Research Cou...erent labs is, however, a balancing act where the ...erial need to be weighed against the need for comp...scale up the production of human embryonic stem ce...
Other Biology News:Stem cell chicken and egg debate moves to unlikely arena: the testes 2Stem cell chicken and egg debate moves to unlikely arena: the testes 3Researcher helping to pioneer medical therapy for Fragile X Syndrome presents latest findings 2Standards in stem cell research 2Standards in stem cell research 3
Mouse Anti-Rat Kappa, Lambda Light Chain Monoclonal Antibody, Horseradish Peroxidase Conjugated from AbD Serotec
Bovine Serum Albumin Peroxidase Stabilizer Solution from BioFX Laboratories, Inc.
GELase 50X Reaction Buffer from EPICENTRE Biotechnologies
Axl, phospho ELISA development Kit, DuoSet, IC (Intracellular) from R&D Systems
Biology Products: